https://www.live-feeds.com/feed/the-holy-grail-in-cancer-fda-panel-backs-blood-testsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/the-holy-grail-in-cancer-fda-panel-backs-blood-testshttps://www.live-feeds.com/feed/the-holy-grail-in-cancer-fda-panel-backs-blood-tests#u84405Sat, 26 Sep 2026 00:05:27 +0000An FDA advisory panel voted to endorse the benefits of Grail's multi-cancer early detection blood test. The test aims to identify signs of various cancers in people who appear healthy. While the panel cleared a major hurdle toward official FDA approval, some advisers issued warnings regarding the test's implementation. The technology is designed to screen for up to 50 different types of cancer through a single blood draw, though experts continue to debate the evidence and readiness for widespread clinical use.Why it mattersEarly detection often improves cancer survival rates by ident